A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrheic dermatitis

Journal of Dermatological Treatment

Volumn 11, Issue 2, 2000, Pages 73-77

  Vardy, Daniel A ^a,b,d   Zvulunov, A ^a,b   Tchetov, T ^a   Biton, A ^a,b   Rosenman, D ^c  

^a CLALIT HEALTH SERVICES   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HAEMEK MEDICAL CENTER   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Ciclopirox olamine shampoo; Seborrheic dermatitis

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; SHAMPOO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY SKIN; FOLLOW UP; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SEBORRHEIC DERMATITIS; SIDE EFFECT; TIME;

EID: 0033944398     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630050517441     Document Type: Article

References (16)

1. Heng MC, Henderson CL, Barker DC, Haberfeld G, Correlation of pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol (1990) 23: 82-6.
2. Peter RU, Richarz-Barthauer U, Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol (1995) 132: 441-5.
3. Danby FW, Maddin WS, Margesson LJ, Rosenthal D, A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol (1993) 29: 1008-12.
4. Segal R, David M, Ingber A et al, Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study. Acta Derm Venereol (1992) 72: 454-5.
5. Zeharia A, Mimouni M, Fogel D, Treatment with bifonazole shampoo for scalp seborrhea in infants and young children. Pediatr Dermatol (1996) 13: 151-3.
6. Abrams BB, Hanel H, Hoehler T, Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol (1991) 9: 471-7.
7. Jue SG, Dawson GW, Brogden RN, Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs (1985) 29: 330-41.
8. Sehgal VN, Ciclopirox: a new topical pyrodonium antimycotic agent. A double-blind study in superficial dermatomycoses. Br J Dermatol (1976) 95: 83-8.
9. Aly R, Maibach HI, Bagatell FK et al, Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther (1989) 11: 290-303.
10. Bogaert H, Cordero C, Ollague W et al, Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris. J Int Med Res (1986) 14: 210-16.
11. Jager SU, Ponninghaus JM, Koch P, Allergic contact dermatitis from ciclopiroxolamine? Contact Dermatitis (1995) 33: 349-50.
12. Ashbee HR, Ingham E, Hollnad KT, Cunliffe WK, Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls. Exp Dermatol (1994) 3: 106-12.
13. Bergbrant IM, Johansson S, Robbins D et al, An immunological study in patients with seborrheic dermatitis. Clin Exp Dermatol (1991) 16: 331-8.
14. Parry ME, Sharpe GR, Seborrheic dermatitis is not caused by an altered immune response to Malassezia yeast. Br J Dermatol (1998) 139: 254-63.
15. Shuttleworth D, Squire RA, Boorman GC, Goode K, Comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) or ketoconazole (2%: Nizoral™) for the control of dandruff/seborrhoeic dermatitis. J Dermatol Treat (1998) 9: 157-62.
16. Shuttleworth D, Galloway DB, Boorman GC, Donald AE, A double-blind, placebo-controlled study of the clinical efficacy of ciclopirox olamine (1.5%) shampoo for the control of scalp psoriasis. J Dermatol Treat (1998) 9: 163-7.